Default: Diabetes/Metabolism Research and Reviews

ISSN: 1520-7552

Journal Home

Journal Guideline

Diabetes/Metabolism Research and Reviews Q1 Unclaimed

John Wiley and Sons Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Diabetes/Metabolism Research and Reviews is a journal indexed in SJR in Endocrinology and Endocrinology, Diabetes and Metabolism with an H index of 135. It has a price of 2500 €. It has an SJR impact factor of 1,991 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,991.

Diabetes/Metabolism Research and Reviews focuses its scope in these topics and keywords: diabetes, related, obesity, insulin, insomnia, independent, levels, ligand, sociodemographic, matrix, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Metrics

Diabetes/Metabolism Research and Reviews

1,991

SJR Impact factor

135

H Index

101

Total Docs (Last Year)

346

Total Docs (3 years)

5097

Total Refs

2518

Total Cites (3 years)

311

Citable Docs (3 years)

5.14

Cites/Doc (2 years)

50.47

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


diabetes, related, obesity, insulin, insomnia, independent, levels, ligand, sociodemographic, matrix, latin, medication, mrna, nephropathyvitamin, overweight, patients, populationbased, resistance, review, historical, genome, functionphysical, adolescents, americarisk, cell, chemokine, children, cohort, cxc, deficiency, determinants, diabetesprevalence, diabetic, elrnegative, extracellular, french,



Best articles by citations

Glucose control in diabetes

View more

Nocturnal hypoglycaemia in type 1 diabetes?consequences and assessment

View more

Mitochondrial dysfunction as a central event for mechanisms underlying insulin resistance: the roles of long chain fatty acids

View more

Asymptomatic hypoglycaemia: identification and impact

View more

Introduction

View more

Challenges in optimal metabolic control of diabetes

View more

The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk

View more

Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose

View more

LDL oxidative modifications in well- or moderately controlled type 2 diabetes

View more

Continuous glucose monitoring in managing diabetes in children

View more

The metabolic demands of driving for drivers with type 1 diabetes mellitus

View more

Is insulin resistance caused by defects in insulin's target cells or by a stressed mind?

View more
SHOW MORE ARTICLES

The antidiabetic agent, gliclazide, reduces high insulin-enhanced neutrophil-transendothelial migration through direct effects on the endothelium

View more

Improved insulin secretory function and reduced chemotactic properties after tissue culture of islets from type 1 diabetic patients

View more

Wound healing - a practical algorithm

View more

Lymphatic system changes in diabetes mellitus: role of insulin and hyperglycemia

View more

Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease(the DIABFIN study)

View more

The epidemiology of diabetes mellitus: an international perspective Jean-Marie Ekoe, Paul Zimmet and Rhys Williams (eds) Chichester, UK: John Wiley & Sons Ltd, 2001. No. of pages 454. ISBN: 0 471 97448 X

View more

Management of cerebral oedema in diabetes

View more

HUVECs from newborns with a strong family history of diabetes show diminished ROS synthesis in the presence of high glucose concentrations

View more

The role of taurine in diabetes and the development of diabetic complications

View more

Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus

View more

Glucose-responsive insulin-producing cells from stem cells

View more

Design and development of a scale measuring fear of complications in type 1 diabetes

View more

FAQS